Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Liver fibrosis is characterized by the excessive accumulation of extracellular matrix proteins. Electrical conductivity imaging at low frequency can provide novel contrast because the contrast mechanisms originate from the changes in the concentration and mobility of ions in the extracellular space.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To evaluate the feasibility of an MR‐based electrical conductivity imaging that can detect the changes in a tissue condition associated with the progression of liver fibrosis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Prospective phantom and animal study.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Animal Model</h3><p>Fibrosis was induced by weekly intraperitoneal injection of dimethylnitrosamine (DMN) in 45 male Sprague–Dawley rats.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>3T MRI with a multispin‐echo pulse sequence.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>The percentage change of conductivity (Δ<i>σ </i>, %) in the same region‐of‐interest (ROI) was calculated from the DMN‐treated rats based on the values of the normal control rats. The percentage change was also calculated between the ROIs in each DMN‐treated group. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>One‐way analysis of variance (ANOVA) and a two‐sample <i>t </i>‐test were performed. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Liver tissues in normal control rats showed a uniform conductivity distribution of 56.6 ± 4.4 (mS/m). In rats more than 5 weeks after induction, the fibrous region showed an increased conductivity of ≥12% compared to that of the corresponding normal control rats. From regional comparisons in the same liver, the fibrous region showed an increased conductivity of ≥11% compared to the opposite, less induced region of rats more than 5 weeks after induction. Liver samples from the fibrous region represent tissue damages such as diffuse centrilobular congestion with marked dilatation of central veins from the histological findings. Immunohistochemistry revealed significant levels of attenuated fibrosis and increased inflammatory response.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The increased conductivity in the fibrous region is related to the changes of the extracellular space. The correlation between the collagen deposition and conductivity changes is essential for future clinical studies.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>2</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>2</p></section>

In Vivo Lipid Profiling Using Proton Magnetic Resonance Spectroscopy in an Experimental Liver Fibrosis Model.

In Vivo Proton Magnetic Resonance Spectroscopy of Hepatic Ischemia/Reperfusion Injury in an Experimental Model

Dynamic Changes of Key Metabolites During Liver Fibrosis in Rats.

[Values of Magnetic Resonance Spectrum Imaging in the Diagnosis of Hepatic Fibrosis of Rats].

H-1 nuclear magnetic resonance applied to hepatic fibrosis of rat liver tissues

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

[Measurement of Intrahepatic Triglyceride Stores by 1H Magnetic Resonance Spectroscopy: Study with Rat Models and in Patients].

In vivo 1H MR spectroscopy in the evaluation of the serial development of hepatocarcinogenesis in an experimental rat model.

Measurement of Liver T1 and T2 Relaxation Times in an Experimental Mouse Model of Liver Fibrosis

Assessment of Liver Fibrosis by Variable Flip Angle T-1 Mapping at 3.0T

Staging of Liver Fibrosis Treated with Hepatocyte Growth Factor by Ultrasound Cationic Microbubble Nano-Liposomes Using 1H Magnetic Resonance Spectroscopy

Molecular Magnetic Resonance Imaging of Activated Hepatic Stellate Cells with Ultrasmall Superparamagnetic Iron Oxide Targeting Integrin αvβ3 for Staging Liver Fibrosis in Rat Model

The value of 1 H-MRS combined with gradient-echo chemical shift MRI in quantitative evalu- ation of fatty liver

Quantification of Liver Fat Content by 1 H-MR Spectroscopy Imaging at 3.0 T for Therapeutic Evaluation of Fatty Liver - Preliminary Study

Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model

Diffusion Tensor Imaging of Liver Fibrosis in an Experimental Model

Three-dimensional Magnetic Resonance Elastography Combining Proton-Density Fat Fraction Precisely Identifies Metabolic Dysfunction-Associated Steatohepatitis with Significant Fibrosis

Molecular mri of liver fibrosis by fibrin-fibronectin targeted contrast agent in an experimental mouse model

MR‐Based Electrical Conductivity Imaging of Liver Fibrosis in an Experimental Rat Model

Quantification of Liver Fat Content by ~1H-MR Spectroscopy Combined with Chemical Shift Gradient-Echo MR Imaging at 3.0T for Therapeutic Evaluation of Fatty Liver——a Preliminary Study

Magnetic Resonance Quantitative Susceptibility Mapping in the Evaluation of Hepatic Fibrosis in Chronic Liver Disease: a Feasibility Study